# Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

> **NCT06118398** · — · UNKNOWN · sponsor: **Feng Jinzhou** · enrollment: 24 (estimated)

## Conditions studied

- Neuromyelitis Optica
- Efgartigimod

## Interventions

- **DRUG:** Intravenous methylprednisolone (IVMP) and Efgartigimod
- **DRUG:** IVMP

## Key facts

- **NCT ID:** NCT06118398
- **Lead sponsor:** Feng Jinzhou
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-05
- **Primary completion:** 2024-11-05
- **Final completion:** 2025-05-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06118398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06118398, "Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06118398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*